Search - tctmd.com

Displaying 41 - 60 of 617

Sort: Relevancy | Date

News Conference News STS 2025

Surgery Outdoes Percutaneous Treatment for Patients With CAD, Aortic Stenosis

Yael L. Maxwell

February 05, 2025

News Daily News

Deferred Revascularization Safer When Guided by FFR vs QFR: FAVOR III Europe

Caitlin E. Cox

January 09, 2025

News Opinion Editor's Corner

TCTMD’s Biggest News of 2024: Stories, Videos, and More

Shelley Wood

January 01, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for December 2024

Caitlin E. Cox

December 31, 2024

News Daily News

Immediate Angiography in OHCA Without STEMI Could Harm: TOMAHAWK and COACT

Caitlin E. Cox

December 27, 2024

News Daily News

BMJ Investigation Revives Questions About PLATO, Ticagrelor

Todd Neale

December 20, 2024

News Daily News

New Platelet Function, Genetic Testing Consensus Seeks to Fill Gaps—Again

Yael L. Maxwell

November 27, 2024

News Conference News AHA 2024

ZODIAC: Decision-Support Tool Doesn’t Sway Lipid-Lowering Treatments in ACS

Michael O'Riordan

November 21, 2024

News Conference News AHA 2024

ENBALV: Edoxaban Matches Warfarin After Bioprosthetic Valve Surgery

Yael L. Maxwell

November 17, 2024

News Conference News AHA 2024

One Hundred Years and Beyond: What's Going to Be Hot at AHA 2024

Shelley Wood

November 14, 2024

News Daily News

Rosuvastatin Bests Atorvastatin for Reducing CVD Risk: Registry Data

Michael O'Riordan

November 07, 2024

Presentation TCT 2024

TCT 218: Angiographic Quantitative Flow Ratio-Guided Coronary Intervention in Patients With and Without Multivessel Disease: A Pre-Specified Substudy From the FAVOR III China Trial

Presenter: han zhang

October 29, 2024

Presentation TCT 2024

TCT 18: The Impact of Coronary Physiology on the Initial Treatment Strategy for Percutaneous Coronary Intervention: Insights From FAVOR III China Trial

Presenter: Hao-Yu Wang

October 29, 2024

News Daily News

Level of Consciousness After Cardiac Arrest Correlates With Post-PCI Outcomes

Yael L. Maxwell

October 25, 2024

News Conference News EACTS 2024

Will Semaglutide Change Cardiac Surgery? It Already Has

Yael L. Maxwell

October 10, 2024

News Conference News ESC 2024

ESC’s 2024 CCS Guidelines Embrace New Data, Smooth Old Tensions

Michael O'Riordan

September 17, 2024

News Daily News

Little Pre- and Postmarket Testing for Most Recalled CV Devices

Michael O'Riordan

September 16, 2024

News Conference News ESC 2024

AI Tool Fails to Boost Outcomes in ED Triage of Suspected CV Conditions

Caitlin E. Cox

September 12, 2024

News Conference News ESC 2024

More Support for Ticagrelor Monotherapy After PCI, Especially in ACS

Yael L. Maxwell

September 10, 2024

News Conference News ESC 2024

More Data Diminish Support for Cath Lab Fasting Rules: SCOFF

L.A. McKeown

September 10, 2024

Advertisement

Surgery Outdoes Percutaneous Treatment for Patients With CAD, Aortic Stenosis

Deferred Revascularization Safer When Guided by FFR vs QFR: FAVOR III Europe

TCTMD’s Biggest News of 2024: Stories, Videos, and More

TCTMD’s Top 10 Most Popular Stories for December 2024

Immediate Angiography in OHCA Without STEMI Could Harm: TOMAHAWK and COACT

BMJ Investigation Revives Questions About PLATO, Ticagrelor

New Platelet Function, Genetic Testing Consensus Seeks to Fill Gaps—Again

ZODIAC: Decision-Support Tool Doesn’t Sway Lipid-Lowering Treatments in ACS

ENBALV: Edoxaban Matches Warfarin After Bioprosthetic Valve Surgery

One Hundred Years and Beyond: What's Going to Be Hot at AHA 2024

Rosuvastatin Bests Atorvastatin for Reducing CVD Risk: Registry Data

TCT 218: Angiographic Quantitative Flow Ratio-Guided Coronary Intervention in Patients With and Without Multivessel Disease: A Pre-Specified Substudy From the FAVOR III China Trial

TCT 18: The Impact of Coronary Physiology on the Initial Treatment Strategy for Percutaneous Coronary Intervention: Insights From FAVOR III China Trial

Level of Consciousness After Cardiac Arrest Correlates With Post-PCI Outcomes

Will Semaglutide Change Cardiac Surgery? It Already Has

ESC’s 2024 CCS Guidelines Embrace New Data, Smooth Old Tensions

Little Pre- and Postmarket Testing for Most Recalled CV Devices

AI Tool Fails to Boost Outcomes in ED Triage of Suspected CV Conditions

More Support for Ticagrelor Monotherapy After PCI, Especially in ACS

More Data Diminish Support for Cath Lab Fasting Rules: SCOFF

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content